Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)

Musa Yilmaz; Mansour Alfayez; Courtney D. DiNardo; Gautam Borthakur; Tapan M. Kadia; Marina Y. Konopleva; Sanam Loghavi; Rashmi Kanagal-Shamanna; Keyur P. Patel; Elias J. Jabbour; Guillermo Garcia‑Manero; Naveen Pemmaraju; Sherry A. Pierce; Issa Ghayas; Nicholas J. Short; Guillermo Montalban-Bravo; Koichi Takahashi; Rita Assi; Ahmad S. Alotaibi; Maro Ohanian; Michael Andreeff; Jorge E. Cortes; Hagop M. Kantarjian; Farhad Ravandi; Naval G. Daver

doi:10.1186/s13045-020-01023-9

Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)

Musa Yilmaz, Mansour Alfayez, Courtney D. DiNardo, Gautam Borthakur, Tapan M. Kadia, Marina Y. Konopleva, Sanam Loghavi, Rashmi Kanagal-Shamanna, Keyur P. Patel, Elias J. Jabbour, Guillermo Garcia‑Manero, Naveen Pemmaraju, Sherry A. Pierce, Issa Ghayas, Nicholas J. Short, Guillermo Montalban-Bravo, Koichi Takahashi, Rita Assi, Ahmad S. Alotaibi, Maro OhanianMichael Andreeff, Jorge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi, Naval G. Daver

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

The original article [18] mistakenly contains duplicate references. The correct reference list can be viewed in this Correction article.

Original language	English (US)
Article number	34
Journal	Journal of Hematology and Oncology
Volume	14
Issue number	1
DOIs	https://doi.org/10.1186/s13045-020-01023-9
State	Published - Dec 2021

ASJC Scopus subject areas

Hematology
Molecular Biology
Oncology
Cancer Research

MD Anderson CCSG core facilities

Flow Cytometry and Cellular Imaging Facility

Access to Document

10.1186/s13045-020-01023-9

Cite this

Yilmaz, M., Alfayez, M., DiNardo, C. D., Borthakur, G., Kadia, T. M., Konopleva, M. Y., Loghavi, S., Kanagal-Shamanna, R., Patel, K. P., Jabbour, E. J., Garcia‑Manero, G., Pemmaraju, N., Pierce, S. A., Ghayas, I., Short, N. J., Montalban-Bravo, G., Takahashi, K., Assi, R., Alotaibi, A. S., ... Daver, N. G. (2021). Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5). Journal of Hematology and Oncology, 14(1), Article 34. https://doi.org/10.1186/s13045-020-01023-9

Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5). / Yilmaz, Musa; Alfayez, Mansour; DiNardo, Courtney D. et al.
In: Journal of Hematology and Oncology, Vol. 14, No. 1, 34, 12.2021.

Research output: Contribution to journal › Comment/debate › peer-review

@article{148da7c8e8dc4877b9d3abc0c1fccc99,

title = "Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)",

abstract = "The original article [18] mistakenly contains duplicate references. The correct reference list can be viewed in this Correction article.",

author = "Musa Yilmaz and Mansour Alfayez and DiNardo, {Courtney D.} and Gautam Borthakur and Kadia, {Tapan M.} and Konopleva, {Marina Y.} and Sanam Loghavi and Rashmi Kanagal-Shamanna and Patel, {Keyur P.} and Jabbour, {Elias J.} and Guillermo Garcia‑Manero and Naveen Pemmaraju and Pierce, {Sherry A.} and Issa Ghayas and Short, {Nicholas J.} and Guillermo Montalban-Bravo and Koichi Takahashi and Rita Assi and Alotaibi, {Ahmad S.} and Maro Ohanian and Michael Andreeff and Cortes, {Jorge E.} and Kantarjian, {Hagop M.} and Farhad Ravandi and Daver, {Naval G.}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1186/s13045-020-01023-9",

language = "English (US)",

volume = "14",

journal = "Journal of Hematology and Oncology",

issn = "1756-8722",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)

AU - Yilmaz, Musa

AU - Alfayez, Mansour

AU - DiNardo, Courtney D.

AU - Borthakur, Gautam

AU - Kadia, Tapan M.

AU - Konopleva, Marina Y.

AU - Loghavi, Sanam

AU - Kanagal-Shamanna, Rashmi

AU - Patel, Keyur P.

AU - Jabbour, Elias J.

AU - Garcia‑Manero, Guillermo

AU - Pemmaraju, Naveen

AU - Pierce, Sherry A.

AU - Ghayas, Issa

AU - Short, Nicholas J.

AU - Montalban-Bravo, Guillermo

AU - Takahashi, Koichi

AU - Assi, Rita

AU - Alotaibi, Ahmad S.

AU - Ohanian, Maro

AU - Andreeff, Michael

AU - Cortes, Jorge E.

AU - Kantarjian, Hagop M.

AU - Ravandi, Farhad

AU - Daver, Naval G.

PY - 2021/12

Y1 - 2021/12

N2 - The original article [18] mistakenly contains duplicate references. The correct reference list can be viewed in this Correction article.

AB - The original article [18] mistakenly contains duplicate references. The correct reference list can be viewed in this Correction article.

UR - http://www.scopus.com/inward/record.url?scp=85101342269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101342269&partnerID=8YFLogxK

U2 - 10.1186/s13045-020-01023-9

DO - 10.1186/s13045-020-01023-9

M3 - Comment/debate

C2 - 33618754

AN - SCOPUS:85101342269

SN - 1756-8722

VL - 14

JO - Journal of Hematology and Oncology

JF - Journal of Hematology and Oncology

IS - 1

M1 - 34

ER -

Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)

Abstract

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Fingerprint

Cite this